Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pfizer Inc. sell Traumtanz

Start price
€30.91
17.12.20 / 50%
Target price
€29.00
Performance (%)
-1.81%
End price
€30.35
21.12.20
Summary
This prediction ended on 21.12.20 with a price of €30.35. With a performance of -1.81%, the SELL prediction by Traumtanz was trending in the right direction. Traumtanz has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Pfizer Inc. -2.037% -2.037% -31.980% -25.222%
iShares Core DAX® -0.992% -3.231% 11.661% 16.545%
iShares Nasdaq 100 -0.225% -3.339% 36.491% 43.334%
iShares Nikkei 225® -0.736% -7.859% 18.597% 4.253%
iShares S&P 500 -0.509% -2.979% 26.341% 40.911%

According to Traumtanz what are the pros and cons of Pfizer Inc. for the foreseeable future?

Pros
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Top 10 in its market
Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Cons
Higher risks for its business
Significant cyclical dependencies

Comments by Traumtanz for this prediction

In the thread Pfizer Inc. diskutieren
Prediction Sell
Perf. (%) -1.81%
Target price 40.000
Change
Ends at

Sell mit Kursziel 40,0

Prediction Sell
Perf. (%) -1.81%
Target price 30.000
Change
Ends at

Kursziel geändert auf 30,0

Prediction Sell
Perf. (%) -1.81%
Target price 29.000
Change
Ends at

Kursziel geändert auf 29,0

In the thread Trading Pfizer Inc.
Prediction Buy
Perf. (%) -1.81%
Target price 29.000
Change
Ends at

Sell beendet

Stopped prediction by Traumtanz for Pfizer Inc.

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.70
22.05.23
€50.00
22.05.24
1.68%
08.06.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.95
22.05.23
€50.00
31.07.23
5.15%
22.05.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.24
31.07.22
€50.00
31.07.23
-31.05%
22.05.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.30
09.11.20
€37.95
-11.94%
17.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.93
25.08.20
€25.62
03.09.20
-2.45%
03.09.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.70
16.07.20
€33.21
25.08.20
4.15%
25.08.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.84
01.07.20
€42.69
08.07.20
-2.30%
08.07.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio